Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
CJC-1295 (NO DAC) + Ipamorelin Blend Peptide Research Applications & Key Findings Growth Hormone Secretion Research Pituitary Function Studies Extensive research has examined the growth hormone secretagogue properties of the CJC-1295 + Ipamorelin combination across multiple species: Dose-dependent GH release demonstrated in rat anterior pituitary cell cultures with picomolar to micromolar peptide concentrations 2- to 10-fold increases in plasma growth hormone levels sustained for 6 days in human subjects following single CJC-1295 dose Preserved pulsatile secretion with ipamorelin addition, preventing continuous non-physiological stimulation Selective action on growth hormone release without affecting prolactin, ACTH, cortisol, FSH, or TSH levels Human trials with healthy subjects aged 21-61 years demonstrated sustained, dose-dependent increases in growth hormone and IGF-1 levels that were safe and well-tolerated at doses of 30-60 mcg/kg
Initial consultations and lab work are required before starting treatment
How can I tell if my GLP-1 medication dosage needs to be adjusted
Crucially, denominators must be explicit (e.g., per started cycle vs
I made my appointment just an hour beforehand on a Sunday morning
US$ 25.97
US$ 28.78
US$ 24.36
US$ 21.63
US$ 26.20
US$ 25.39
US$ 23.38
US$ 21.79
US$ 20.05
US$ 22.88
US$ 21.03
US$ 28.36
US$ 28.98
